华邦健康跌2.17%，成交额1.19亿元，主力资金净流出1313.42万元

Core Viewpoint - Huabang Health's stock price has shown fluctuations, with a recent decline of 2.17% and a year-to-date increase of 15.02%, indicating mixed investor sentiment and market performance [1][2]. Financial Performance - For the first half of 2025, Huabang Health reported a revenue of 5.945 billion yuan, reflecting a year-on-year growth of 0.39%, while the net profit attributable to shareholders reached 388 million yuan, marking a significant increase of 23.90% [2]. - Cumulatively, the company has distributed 4.909 billion yuan in dividends since its A-share listing, with 1.265 billion yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 3.86% to 73,800, while the average circulating shares per person increased by 3.99% to 25,486 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 1.599 million shares to 21.982 million shares, and Invesco Great Wall CSI Dividend Low Volatility 100 ETF, which reduced its holdings by 550,200 shares to 15.6347 million shares [3]. Market Activity - The stock experienced a trading volume of 119 million yuan with a turnover rate of 1.26%, and the main funds saw a net outflow of 13.1342 million yuan, indicating a cautious market sentiment [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with a net buy of -13.4632 million yuan on January 20, 2025 [1].